Cancer immunotherapy-associated hypophysitis-Reference-Cited by-同舟云学术

Cancer immunotherapy-associated hypophysitis

Published:2018-06 Issue:3 Volume:45 Page:181-186
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Solinas Cinzia,Porcu Michele^ORCID,De Silva Pushpamali,Musi Marco,Aspeslagh Sandrine^ORCID,Scartozzi Mario,Willard-Gallo Karen^ORCID,Mariotti Stefano,Saba Luca

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference35 articles.

1. Management of adverse events following treatment with anti-programmed death-1 agents;Weber;Oncologist,2016

2. Management of immune-related adverse events and kinetics of response with ipilimumab;Weber;J Clin Oncol,2012

3. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma;Weber;J Clin Oncol,2017

4. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpointinhibitors for metastatic melanoma;Scott;Eur J Endocrinol,2018

5. Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events;Kwak;Radiographics,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy;Expert Review of Clinical Immunology;2024-07-16

2. Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review;BMC Pulmonary Medicine;2024-07-08

3. Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literature review;Frontiers in Immunology;2024-01-16

4. Adrenal crisis mainly manifested as recurrent syncope secondary to Tislelizumab:a case report and literature review;2023-08-23

5. Pituitary metastasis of salivary gland carcinoma mimicking hypophysitis: A case report and literature review;International Journal of Surgery Case Reports;2023-08